Epigenetic editing of BRCA1 promoter increases cisplatin and olaparib sensitivity of ovarian cancer cells

Wanhong Hea Shanghai-MOST Key Laboratory of Health and Disease Genomics, NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, ChinaView further author information

Haijun Zhua Shanghai-MOST Key Laboratory of Health and Disease Genomics, NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, ChinaView further author information

Sufen Zhanga Shanghai-MOST Key Laboratory of Health and Disease Genomics, NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, ChinaView further author information

Guang Shub Department of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, ChinaView further author information

Han Leib Department of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, ChinaView further author information

Maonan Wangb Department of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, ChinaView further author information

Gang Yinb Department of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, ChinaView further author information

Xiaohua Nia Shanghai-MOST Key Laboratory of Health and Disease Genomics, NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, ChinaView further author information

Qihan Wua Shanghai-MOST Key Laboratory of Health and Disease Genomics, NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, ChinaCorrespondence[email protected] [email protected]
View further author information

show all

Epigenetic editing of BRCA1 promoter increases cisplatin and olaparib sensitivity of ovarian cancer cells

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Epigenetic editing of BRCA1 promoter increases cisplatin and olaparib sensitivity of ovarian cancer cells

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date